Stable inhibition of nuclear factor κB in cancer cells does not increase sensitivity to cytotoxic drugs

Cancer Research

Volumn 59, Issue 4, 1999, Pages 811-815

  Bentires Alj, Mohamed ^a   Hellin, Anne Cécile ^a   Ameyar, Maya ^b   Chouaib, Salem ^b   Merville, Marie Paule ^a   Bours, Vincent ^a,c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CYTOKINE; CYTOTOXIC AGENT; DAUNORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOMYCIN; PACLITAXEL; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VINBLASTINE SULFATE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; HUMANS; NF-KAPPA B; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033558155     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Siebenlist, U., Franzoso, G., and Brown, K. Structure, regulation, and function of NF-κB. Annu. Rev. Cell. Biol., 10: 405-455, 1994.
2. Perera, P-Y., Qureshi, N., and Vogel, S. N. Paclitaxel (Taxol)-induced NF-κB translocation in murine macrophages. Infect. Immun., 64: 878-884, 1996.
3. Piret, B., and Piette, J. Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells. Nucleic Acids Res., 24: 4242-4248, 1996.
4. Das, K. C., and White, C. W. Activation of NF-κB by anlineoplastic agents. J. Biol. Chem., 272: 14914-14920, 1997.
5. Hellin, A-C., Calmant, P., Gielen, J., Bours, V., and Merville, M-P. Nuclear factor-κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene, 16: 1187-1195, 1997.
6. Yao, K-S., and O'Dwyer, P. J. Involvement of NF-κB in the induction of NAD(P)H: quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol., 3: 275-282, 1995.
7. Brach, M. A., Hass, R., Sherman, M. L., Gunji. H., Weichselbaum, R., and Kufe, D. Ionizing radiation induces expression and binding activity of the nuclear factor κB. J. Clin. Invest., 88: 691-695, 1991.
8. Beg, A. A., and Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Washington DC), 274: 782-784, 1996.
9. Liu, Z., Hsu, H., Goeddel, D. V., and Karin, M Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87: 565-576, 1996.
10. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Washington DC), 274: 787-789, 1996.
11. Wang, C-Y., Mayo, M. W.. and Baldwin, A. S. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
12. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (Lond.), 376: 167-170, 1995.
13. Bertrand, F., Atfi, A., Cadoret, A., L'Allemain, G., Robin, H., Lascols, O., Capeau, J., and Cherqui, G. A role for nuclear factor κB in the antiapoptotic function of insulin. J. Biol. Chem., 275; 2931-2938, 1998.
14. Bargou, R. C., Emmerich, F., Krappmann, D., Bomert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., and Dörken, B. Constitutive Nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest., 100: 2961-2969, 1997.
15. Limuro, Y., Nishiura, T., Hellerbrand, C., Behrns, K. E., Schoonhoven, R., Grisham, J. W., and Brenner, D. A. NFκB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest., 101: 802-811, 1998.
16. Mayo, M. W., Wang, C-Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. C., Der, C. J., and Baldwin, A. S. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (Washington DC), 278: 1812-1815, 1997.
17. Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., Fitzgerald, M. J., Rothstein, T. L., Sherr, D. H., and Sonenshein, G. E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J., 15: 4682-4690, 1996.
18. Sovak, M. A., Bellas, R. E., Kim, D. W., Zanievski, G. J., Rogers, A. E., and Traish, A. M. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest., 100: 2952-2960, 1997.
19. Cai, Z., Körner, M., Tarantino, N., and Chouaib, S. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis. J. Biol. Chem., 272: 96-101, 1997.
20. Li, Y., Zhang, W., Mantell, L. L., Kazzaz, J. A., Fein, A. M., and Horowitz, S. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death. J. Biol. Chem., 272: 20646-20649, 1997.
21. Whiteside, S. T., Ernst, M. K., LeBail, O., Laurent-Winter, C., Rice, N., and Israël, A. N- and C-terminal sequences control degradation of MAD/IκBα in response to inducers of NF-κB activity. Mol. Cell. Biol., 15: 5339-5345, 1995.
22. Ferreira, V., Tarantino, N., and Körner, M. Discrimination between RelA and RelB transcriptional regulation by a dominant negative mutant of IκBα. J. Biol. Chem., 273: 592-599, 1998.
23. Dejardin, E., Bonizzi, G., Bellahcène, A., Castronovo, V., Merville, M-P., and Bours, V. Highly-expressed p100/p52 (NFKB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene, 11: 1835-1841, 1995.
24. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Washington DC), 267: 1485-1488, 1995.
25. Sikic, B. I. Pharmacologic approaches to reversing multidrug resistance. Semin. Hematol., 34: 40-47, 1997.
26. Cai, Z., Stancou, R., Körner, M., and Chouaib, S. Impairment of Fas-antigen expression in Adriamycin-resistant but not TNF-resistant MCF7 tumor cells. Int. J. Cancer, 68: 535-546, 1996.